Professional
Added to YB: 2024-04-30
Pitch date: 2024-03-31
LONN.SW [bullish]
Lonza Group AG
-4.34%
current return
Author Info
No bio for this author
Company Info
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
Market Cap
CHF 41.0B
Pitch Price
CHF 546.95
Price Target
N/A
Dividend
0.69%
EV/EBITDA
24.38
P/E
65.09
EV/Sales
6.78
Sector
Life Sciences Tools and Services
Category
growth
Artisan International Fund Added On Portfolio Holding: Lonza Group AG
LONN.SW: Lonza acquired world's largest biologics manufacturing site from Roche, expected to add $2.8B revenue & $1B EBITDA long-term. Offers drug development & manufacturing services through long-term contracts. Investment expected to be immediately NPV accretive.
Read full article (1 min)